SPTLC2 and Alzheimer disease: The authors additionally demonstrated SPTLC2 and ceramide suppression in primary rat astrocytes that were transfected with either miR-29a or b-1, and observed significant negative correlations between SPTLC2 expression and levels of miR-29a and miR-29b-1 in human sporadic AD frontal cortices.